Free Trial

Oxford Nanopore Technologies (LON:ONT) Shares Down 7.1% - Should You Sell?

Oxford Nanopore Technologies logo with Medical background

Oxford Nanopore Technologies plc (LON:ONT - Get Free Report)'s stock price was down 7.1% during trading on Wednesday . The stock traded as low as GBX 131.40 ($1.71) and last traded at GBX 131.40 ($1.71). 1,443,446 shares were traded during trading, a decline of 25% from the average daily volume of 1,925,887 shares. The stock had previously closed at GBX 141.40 ($1.84).

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on ONT shares. Berenberg Bank reiterated a "buy" rating and issued a GBX 282 ($3.67) price target on shares of Oxford Nanopore Technologies in a research note on Tuesday, September 3rd. Deutsche Bank Aktiengesellschaft restated a "buy" rating and set a GBX 190 ($2.47) price objective on shares of Oxford Nanopore Technologies in a research note on Wednesday, September 4th. Five investment analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the stock currently has a consensus rating of "Buy" and a consensus target price of GBX 235.50 ($3.07).

Read Our Latest Analysis on Oxford Nanopore Technologies

Oxford Nanopore Technologies Trading Up 2.0 %

The company has a market capitalization of £1.26 billion, a PE ratio of -669.50 and a beta of 0.80. The company has a current ratio of 4.45, a quick ratio of 6.01 and a debt-to-equity ratio of 8.07. The company has a fifty day simple moving average of GBX 145.70 and a 200-day simple moving average of GBX 121.56.

Insider Activity at Oxford Nanopore Technologies

In other news, insider Gurdial (Gordon) Sanghera sold 1,993,571 shares of the stock in a transaction on Tuesday, October 15th. The stock was sold at an average price of GBX 142 ($1.85), for a total value of £2,830,870.82 ($3,685,070.06). In the last quarter, insiders bought 323 shares of company stock valued at $44,824. 32.62% of the stock is owned by insiders.

About Oxford Nanopore Technologies

(Get Free Report)

Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a nanopore based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) in the Americas, Europe, the Middle East, Africa, India, and the Asia Pacific.

Featured Articles

Should you invest $1,000 in Oxford Nanopore Technologies right now?

Before you consider Oxford Nanopore Technologies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oxford Nanopore Technologies wasn't on the list.

While Oxford Nanopore Technologies currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Why Whitestone REIT is Outperforming in 2024: 35% Growth & Monthly Dividends
Why SoundHound Stock Dip Could Mean Big Gains for 2025 Investors
Nintendo Stock: Buy Before the 2025 Switch Platform Hits!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines